Long-term therapeutic use of benzodiazepines. II. Effects of gradual taper
- PMID: 2222130
- DOI: 10.1001/archpsyc.1990.01810220024003
Long-term therapeutic use of benzodiazepines. II. Effects of gradual taper
Abstract
We compared the effect on withdrawal severity and acute outcome of a 25% per week taper of short half-life vs long half-life benzodiazepines in 63 benzodiazepine-dependent patients. Patients unable to tolerate taper were permitted to slow the taper rate. Ninety percent of patients experienced a withdrawal reaction, but it was rarely more than mild to moderate. Nonetheless, 32% of long half-life and 42% of short half-life benzodiazepine-treated patients were unable to achieve a drug-free state. The most difficulty was experienced in the last half of taper. Baseline personality, high Eysenck neuroticism, female sex, and mild-to-moderate alcohol use were found to be more significant predictors of withdrawal severity than the daily benzodiazepine dose or benzodiazepine half-life. These findings suggest that personality factors contribute significantly to the patient's difficulties with gradual benzodiazepine discontinuation of therapeutic doses of benzodiazepines.
Similar articles
-
Imipramine and buspirone in treatment of patients with generalized anxiety disorder who are discontinuing long-term benzodiazepine therapy.Am J Psychiatry. 2000 Dec;157(12):1973-9. doi: 10.1176/appi.ajp.157.12.1973. Am J Psychiatry. 2000. PMID: 11097963 Clinical Trial.
-
But what if a patient gets hooked? Fallacies about long-term use of benzodiazepines.Postgrad Med. 1990 Jan;87(1):187-203. doi: 10.1080/00325481.1990.11704533. Postgrad Med. 1990. PMID: 2404264 Review.
-
Thinking about stopping treatment for panic disorder.J Clin Psychiatry. 1990 Dec;51 Suppl A:38-45. J Clin Psychiatry. 1990. PMID: 2258376 Review.
-
Long-term therapeutic use of benzodiazepines. I. Effects of abrupt discontinuation.Arch Gen Psychiatry. 1990 Oct;47(10):899-907. doi: 10.1001/archpsyc.1990.01810220015002. Arch Gen Psychiatry. 1990. PMID: 2222129 Clinical Trial.
-
Long-term benzodiazepine users 3 years after participation in a discontinuation program.Am J Psychiatry. 1991 Jun;148(6):757-61. doi: 10.1176/ajp.148.6.757. Am J Psychiatry. 1991. PMID: 2035717
Cited by
-
The role of pharmacists in deprescribing benzodiazepines: A scoping review.Explor Res Clin Soc Pharm. 2023 Sep 2;12:100328. doi: 10.1016/j.rcsop.2023.100328. eCollection 2023 Dec. Explor Res Clin Soc Pharm. 2023. PMID: 37743854 Free PMC article. Review.
-
Intravenous ketamine for benzodiazepine deprescription and withdrawal management in treatment-resistant depression: a preliminary report.Neuropsychopharmacology. 2023 Nov;48(12):1769-1777. doi: 10.1038/s41386-023-01689-y. Epub 2023 Aug 2. Neuropsychopharmacology. 2023. PMID: 37532888 Free PMC article.
-
Attitudes and Difficulties Associated with Benzodiazepine Discontinuation.Int J Environ Res Public Health. 2022 Nov 30;19(23):15990. doi: 10.3390/ijerph192315990. Int J Environ Res Public Health. 2022. PMID: 36498061 Free PMC article.
-
Novel Designer Benzodiazepines: Comprehensive Review of Evolving Clinical and Adverse Effects.Neurol Int. 2022 Aug 22;14(3):648-663. doi: 10.3390/neurolint14030053. Neurol Int. 2022. PMID: 35997362 Free PMC article. Review.
-
Applying the intervention Complexity Assessment Tool to brief interventions targeting long-term benzodiazepine receptor agonist use in primary care: Lessons learned.BMC Prim Care. 2022 Jul 16;23(1):175. doi: 10.1186/s12875-022-01775-y. BMC Prim Care. 2022. PMID: 35842593 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
